Teri A. ManolioMarc AbramowiczFahd Al-MullaWarwick AndersonRudi BallingAdam C. BergerSteven BleylAravinda ChakravartiWasun ChantratitaRex L. ChisholmVajira H.W. DissanayakeMichael DunnVictor J. DzauBok Ghee HanTim HubbardAnne KolbeBruce KorfMichiaki KuboPaul LaskoErkki LeegoSurakameth MahasirimongkolPartha P. MajumdarGert MatthijsHoward L. McLeodAndres MetspaluPierre MeulienSatoru MiyanoYaakov NaparstekP. Pearl O'RourkeGeorge P. PatrinosHeidi L. RehmMary V. RellingGad RennertLaura Lyman RodriguezDan M. RodenAlan R. ShuldinerSukdeb SinhaPatrick TanMats UlfendahlRobyn WardMarc S. WilliamsJohn E.L. WongEric D. GreenGeofrey S. GinsburgNational Human Genome Research InstituteUniversité libre de Bruxelles (ULB)University of KuwaitAustralian GovernmentUniversity of LuxembourgInstitute of Medicine - WashingtonIntermountain HealthcareThe Johns Hopkins School of MedicineMahidol UniversityNorthwestern University Feinberg School of MedicineUniversity of Colombo Faculty of MedicineWellcome TrustNational Academy of MedicineKorea National Institute of HealthKing's College LondonNational Health CommitteeUniversity of Alabama at BirminghamRikenMcGill UniversityUniversity of TartuThailand Ministry of Public HealthIndian Statistical Institute, KolkataKU LeuvenMoffitt Cancer CenterGenome CanadaInstitute of Medical Science The University of TokyoHadassah University Medical CentrePartners HealthCarePanepistimion PatronSt. Jude Children's Research HospitalCarmel Medical CenterVanderbilt University School of MedicineUniversity of Maryland School of MedicineMinistry of Science And Technology, IndiaDuke-NUS Medical School SingaporeSwedish Research CouncilUniversity of QueenslandGeisinger Health SystemNational University of SingaporeDuke UniversityGenomics England2018-11-232018-11-232015-06-03Science Translational Medicine. Vol.7, No.290 (2015)19466242194662342-s2.0-84930433702https://repository.li.mahidol.ac.th/handle/20.500.14594/36411© 2015, American Association for the Advancement of Science. All rights reserved. Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising from local health care systems, cultural or political milieus, and unusual selected risk alleles or disease burdens. Such individual eforts might beneft from the sharing of approaches and lessons learned in other locales. The U.S. National Human Genome Research Institute and the National Academy of Medicine recently brought together 25 of these groups to compare projects, to examine the current state of implementation and desired near-term capabilities, and to identify opportunities for collaboration that promote the responsible practice of genomic medicine. Eforts to coalesce these groups around concrete but compelling signature projects should accelerate the responsible implementation of genomic medicine in eforts to improve clinical care worldwide.Mahidol UniversityMedicineReviewSCOPUS10.1126/scitranslmed.aab0194